Rockefeller Capital Management L.P. 4 D Molecular Therapeutics, Inc. Transaction History

Rockefeller Capital Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$19.56 - $32.94 $20,929 - $35,245	-1,070 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$22.73 - $36.04 $2,954 - $4,685	-130 Reduced 10.83%	1,070 $28,000
Q2 2021 Aug 10, 2021	SELL	$22.2 - $42.29 $105,117 - $200,243	-4,735 Reduced 79.78%	1,200 $28,000
Q1 2021 May 11, 2021	BUY	$35.94 - $52.67 $213,303 - $312,596	5,935 New	5,935 $257,000

157

50.3M

718K

370K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $675M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.